O
NSPR icon

OrbiMed’s InspireMD NSPR Stock Holding History

OrbiMed’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.11M Hold
3,133,405
– – 0.1% 93
2025
Q4 		$5.58M Buy
3,133,405
+1,000,000
+47% +$2.08M 0.11% 91
2025
Q3 		$5.14M Hold
2,133,405
– – 0.12% 85
2025
Q2 		$4.84M Hold
2,133,405
– – 0.12% 77
2025
Q1 		$5.74M Hold
2,133,405
– – 0.14% 77
2024
Q4 		$5.61M Hold
2,133,405
– – 0.12% 83
2024
Q3 		$5.72M Hold
2,133,405
– – 0.1% 95
2024
Q2 		$5.32M Hold
2,133,405
– – 0.11% 88
2024
Q1 		$5.06M Hold
2,133,405
– – 0.09% 95
2023
Q4 		$5.99M Buy
2,133,405
+273,000
+15% +$786K 0.12% 87
2023
Q3 		$6.08M Hold
1,860,405
– – 0.13% 96
2023
Q2 		$4.67M Buy
+1,860,405
New +$2.96M 0.08% 105
2015
Q1 		– Hold
0
– -$2.45M – 140
2014
Q4 		– Hold
0
– – – 121
2014
Q3 		– Sell
-1
Closed -$15.5M – 107
2014
Q2 		$10M Hold
1
– – 0.12% 86
2014
Q1 		$10.4M Hold
1
– – 0.13% 89
2013
Q4 		$8.35M Hold
1
– – 0.12% 86
2013
Q3 		$7.91M Hold
1
– – 0.14% 88
2013
Q2 		$7.5M Buy
+1
New +$15.6M 0.16% 87

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return

OrbiMed's NSPR Position: Q1 2026 in Review

OrbiMed held its InspireMD (NSPR) position steady in Q1 2026 at 3,133,405 shares worth $5.11M. The position accounts for 0.1% of the portfolio, ranked #93.

OrbiMed first reported a position in NSPR in Q2 2013 and has held it in 17 quarters since. The position peaked at $10.4M in Q1 2014. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • OrbiMed held 3,133,405 shares of InspireMD worth $5.11M as of Q1 2026.
  • OrbiMed left its InspireMD share count unchanged in Q1 2026.
  • InspireMD made up 0.1% of OrbiMed's portfolio in Q1 2026, its #93 holding.
  • OrbiMed first reported a position in InspireMD in Q2 2013 and has held it in 17 quarters since.
  • OrbiMed's InspireMD position peaked at $10.4M in Q1 2014.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on OrbiMed's 13F filing for Q1 2026, filed 15 May 2026.